Proteomics International Laboratories Limited Stock
Equities
PIQ
AU000000PIQ0
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.045 AUD | -4.13% | -3.69% | +16.76% |
Mar. 25 | Proteomics International Signs Agreement with University of Oxford for Endometriosis Study | MT |
Mar. 19 | Proteomics Says PromarkerD's US Launch Delayed | MT |
Sales 2024 * | 2.8M 1.81M | Sales 2025 * | 5.9M 3.82M | Capitalization | 143M 92.44M |
---|---|---|---|---|---|
Net income 2024 * | -7M -4.54M | Net income 2025 * | -5M -3.24M | EV / Sales 2024 * | 48.9 x |
Net cash position 2024 * | 5.7M 3.69M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 24.2 x |
P/E ratio 2024 * |
-19.5
x | P/E ratio 2025 * |
-26.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.87% |
1 day | -4.13% | ||
1 week | -3.69% | ||
Current month | -9.13% | ||
1 month | -9.91% | ||
3 months | +7.73% | ||
6 months | +10.00% | ||
Current year | +16.76% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 14-06-08 | |
Jacqueline Gray
DFI | Director of Finance/CFO | - | 21-07-11 |
Kirsten Peters
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul House
BRD | Director/Board Member | - | 17-11-21 |
Robyn Elliott
BRD | Director/Board Member | 63 | 21-11-15 |
Founder | - | 14-06-08 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 1.045 | -4.13% | 145 841 |
24-04-30 | 1.09 | +1.40% | 77,557 |
24-04-29 | 1.075 | -1.83% | 165,356 |
24-04-26 | 1.095 | +0.46% | 96,997 |
24-04-24 | 1.09 | +0.46% | 65,471 |
Delayed Quote Australian S.E., May 01, 2024 at 02:10 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.76% | 92.65M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.21% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- PIQ Stock